NEW YORK Walgreens Boots Alliance has given more than 20 million COVID-19 vaccinations as of May 24, a top executive said on Tuesday, bringing the company closer to its forecast of giving about 30 million shots this year.
State public health departments are ready to begin giving COVID-19 shots to all adult residents if the White House follows through with the promised shots, state public health officials said during a panel discussion on Tuesday. U.S. President Joe Biden has said he plans to direct states and territories to begin giving COVID-19 shots to any adult who wants one in the beginning of May. He said he expects there will be enough supply available for all adults by the end of that month.
CVS Health Corp said on Tuesday it would return to selling individual health insurance plans on the online marketplaces created by the Affordable Care Act (ACA), popularly known as Obamacare, saying the market had stabilized.
Feb 16 CVS Health Corp said on Tuesday
it would return to selling individual health insurance plans
under the Affordable Care Act (ACA), popularly known as
Obamacare, saying the market had stabilized.
CVS Health Corp said on Tuesday it would return to selling individual health insurance plans under the Affordable Care Act (ACA), popularly known as Obamacare, saying the market had stabilized.
CVS Health Corp Chief Executive Officer Larry Merlo will retire after a decade-long tenure at the helm of the company during which he led the $69 billion acquisition of one of the oldest U.S. health insurer, Aetna.
NEW YORK Walmart Inc, Walgreens Boots Alliance Inc, CVS Health Corp and Rite Aid Corp have told Reuters demand for flu shots at their U.S. pharmacies is up sharply - in some cases double from last year - as people try to protect themselves from influenza in the midst of a worsening COVID-19 pandemic.The pharmacies are giving millions more flu shots than they have in past years, filling a gap from COVID-19 wary consumers who are avoiding the doctor's office. The gains represent millions of dollars in potential profit.
Oct 14 UnitedHealth Group Inc on
Wednesday took a conservative stance toward its expectations for
2021, citing uncertainties related to the COVID-19 pandemic, but
raised its profit forecast for this year after third-quarter
earnings beat estimates.
As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc, could charge up to $10,000 for the treatment.